Detecting cancer-related biomarkers in blood for better treatment decisions
Exosome separation and digital resolution detection of blood-based nucleic acid biomarkers for noninvasive therapeutic diagnostics in cancer
This study is looking at new ways to check tiny molecules in your blood that could help doctors understand how well your cancer treatment is working, so they can make changes if needed, all without any complicated procedures.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Urbana-Champaign NIH-funded |
| Lab location | 1 site (Champaign, United States) |
| Project ID | NIH-10618797 on NIH RePORTER |
What this research studies
This research focuses on developing new technologies to measure specific microRNAs (miRNAs) in blood samples, which can help predict how well cancer treatments will work for individual patients. By analyzing these biomarkers, the goal is to provide doctors with timely and accurate information to adjust therapies as needed. The approach aims to be noninvasive and efficient, allowing for frequent monitoring without the need for complex procedures. This could lead to more personalized and effective cancer treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients undergoing treatment who require monitoring of their response to therapies.
Not a fit: Patients with non-cancerous conditions or those not currently receiving cancer treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enable more personalized cancer treatments by allowing for real-time monitoring of treatment efficacy through blood tests.
How similar studies have performed: Previous research has shown promise in using blood-based biomarkers for cancer detection and treatment monitoring, indicating a potential for success with this innovative approach.
Where this research is happening
Champaign, United States
- University of Illinois at Urbana-Champaign — Champaign, United States (Active)
Researchers
- Principal investigator: Cunningham, Brian T. — University of Illinois at Urbana-Champaign
- Study coordinator: Cunningham, Brian T.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.